Publication | Closed Access

Phase I trial of r viscumin (INN: aviscumine) given subcutaneously in patients with advanced cancer: A study of the European Organisation for Research and Treatment of Cancer (EORTC protocol number 13001)

Advanced CancerEuropean OrganisationR ViscuminMedicineMetronomic TherapyClinical TrialsPharmacotherapyAnti-cancer AgentDermatologyCancer TreatmentOncologyRadiation OncologyCancer ResearchHealth Sciences